Scienture Holdings, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Shankar Hariharan, with a market cap of $16.9M.
Upcoming earnings announcement for Scienture Holdings, Inc.
Past 12 earnings reports for Scienture Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$1.76Est: -$0.28 | -528.6% | -$168.7K | — | |
| Nov 13, 2025 | Q3 2025 | -$0.19 | — | $590.1K | — | |
| Aug 12, 2025 | Q2 2025 | -$0.48 | — | - | — | |
| May 12, 2025 | Q1 2025 | -$0.33 | — | $10.3K | — | |
| Mar 26, 2025 | Q4 2024 | -$0.76 | — | $53.1K | — | |
| Nov 6, 2024 | Q3 2024 | -$1.34 | — | $64.9K | — | |
| Aug 9, 2024 | Q2 2024 | -$1.16 | — | $18.7M | — | |
| Jun 26, 2024 | Q1 2024 | -$6.40 | — | - | — | |
| Apr 22, 2024 | Q4 2023 | -$2.93 | — | $2.4MEst: $2.4M | +0.1% | |
| Jan 16, 2024 | Q3 2023 | -$0.07Est: -$0.15 | +53.3% | $2.1MEst: $2.3M | -9.7% | — |
| Aug 18, 2023 | Q2 2023 | -$0.77Est: -$0.75 | -2.7% | $2.3MEst: $2.1M | +9.3% | — |
| May 15, 2023 | Q1 2023 | -$0.45Est: -$0.60 | +25.0% | $2.2MEst: $2.7M | -15.5% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.